LabConnect

LabConnect operates as a specialized service provider in the clinical research ecosystem, functioning as a central laboratory partner for pharmaceutical and biotechnology companies. The company differentiates itself through a decentralized, orchestrated model that grants clients access to over 10,000 validated assays across 60+ global locations, coupled with proprietary technology for sample tracking and data management. With experience in over 2,000 clinical trials, including complex areas like cell and gene therapy, oncology, and vaccines, LabConnect aims to accelerate trial timelines and ensure data quality. It is a private, revenue-generating services business that mitigates the logistical and operational burdens of clinical trial sample management for its clients.

A decentralized, orchestrated laboratory network platform powered by a global Test Compendium of 10,000+ assays, SampleGISTICS® for digital sample capture/tracking, and integrated systems for custom collection kit design and logistics.

LabConnect competes with large, full-service Contract Research Organizations (CROs) like Labcorp and IQVIA that have integrated central labs, as well as other independent central laboratory service providers. Its primary differentiation is its decentralized, partner-network model offering access to a vast menu of specialty tests, versus the more traditional in-house testing model of larger competitors.